Literature DB >> 16523275

[A severe course of bullous pemphigoid in a young man].

S Eigelshoven1, D Bruch-Gerharz, E Enderlein, T Ruzicka, A S Büchau, M Hertl, J Reifenberger, K-W Schulte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16523275     DOI： 10.1007/s00105-006-1110-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  6 in total

1.  A case of bullous pemphigoid successfully treated by plasmapheresis: assessment of the change in titers of circulating antibodies by immunoblotting and enzyme-linked immunosorbent assay.

Authors:  Jee Bum Lee; Takeaki Fumimori; Koichiro Kurose; Osamu Mori; Takashi Hashimoto
Journal:  J Dermatol       Date:  2003-04       Impact factor: 4.005

2.  Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.

Authors:  SilkeC Hofmann; Sybille Thoma-Uszynski; Thomas Hunziker; Philippe Bernard; Corinna Koebnick; Angelika Stauber; Gerold Schuler; Luca Borradori; Michael Hertl
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

3.  Guidelines for the management of bullous pemphigoid.

Authors:  F Wojnarowska; G Kirtschig; A S Highet; V A Venning; N P Khumalo
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

4.  Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.

Authors:  J E Herrero-González; C Sitaru; E Klinker; E B Bröcker; D Zillikens
Journal:  Clin Exp Dermatol       Date:  2005-09       Impact factor: 3.470

5.  [Bullous pemphigoid in young patients: a retrospective study of 74 cases].

Authors:  E Bourdon-Lanoy; J-C Roujeau; P Joly; J-C Guillaume; P Bernard; C Prost; E Tancrède-Bohin; E Delaporte; C Picard-Dahan; B Albes; C Bedane; M-S Doutre; O Chosidow; C Lok; C Pauwels; J Chevrand-Breton; B Sassolas; M-A Richard
Journal:  Ann Dermatol Venereol       Date:  2005-02       Impact factor: 0.777

6.  BP230- and BP180-specific auto-antibodies in bullous pemphigoid.

Authors:  Sybille Thoma-Uszynski; Wolfgang Uter; Susanne Schwietzke; Silke C Hofmann; Thomas Hunziker; Philippe Bernard; Regina Treudler; Christos C Zouboulis; Gerold Schuler; Luca Borradori; Michael Hertl
Journal:  J Invest Dermatol       Date:  2004-06       Impact factor: 8.551
  6 in total
  1 in total

1.  [Paraneoplastic bullous pemphigoid in a man with breast and prostate cancer].

Authors:  A S Antal; S Grieb; B Homey; U R Hengge; G Schuett; N J Neumann; R Kruse
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.